Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/RD9.0000000000000027
- Scopus: eid_2-s2.0-85143657870
- Find via

Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Use of biological and chemical molecules in regulating embryo implantation and endometrial receptivity
| Title | Use of biological and chemical molecules in regulating embryo implantation and endometrial receptivity |
|---|---|
| Authors | |
| Keywords | Birth control Embryo implantation Emergency contraception Endometrial receptivity In vitro fertilization Repeated implantation failure |
| Issue Date | 1-Dec-2022 |
| Publisher | Wolters Kluwer Health |
| Citation | Reproductive and Developmental Medicine, 2022, v. 6, n. 4, p. 234-242 How to Cite? |
| Abstract | This review summarizes the drugs and chemicals that may modulate embryo implantation. Non-hormonal molecules, including aspirin, improved endometrial blood flow, while low molecular weight heparin, vitamin E, sildenafil, and atosiban modulated the expression of endometrial genes. Hormonal factors, including human chorionic gonadotropin and growth hormones, can regulate the expression of endometrial receptivity markers. Other immunomodulatory molecules, including granulocyte colony-stimulating factor, peripheral blood mononuclear cells, autologous platelet-rich plasma, and intralipid and intravenous immunoglobulins, may improve implantation rate by modulating endometrial immune functions. Medicinal extracts of the Chinese herbs Paeonia lactiflora and Perilla frutescens increased the expression of leukemia inhibitory factors in endometrial epithelial cells. Recently, the use of the commercially available Library of Pharmacologically Active Compounds with a high-throughput screening method has provided an approach to screen for compounds that may potentially enhance or suppress embryo implantation. Whether these biomedical findings translate into clinical effects that enhance or suppress embryo implantation requires further investigation. |
| Persistent Identifier | http://hdl.handle.net/10722/368142 |
| ISSN | 2023 Impact Factor: 0.7 2023 SCImago Journal Rankings: 0.199 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chen, Xian | - |
| dc.contributor.author | Sun, Shu Ya | - |
| dc.contributor.author | Ng, Ernest Hung Yu | - |
| dc.contributor.author | Li, Raymond Hang Wun | - |
| dc.contributor.author | Yeung, William Shu Biu | - |
| dc.contributor.author | Lee, Kai Fai | - |
| dc.date.accessioned | 2025-12-24T00:36:28Z | - |
| dc.date.available | 2025-12-24T00:36:28Z | - |
| dc.date.issued | 2022-12-01 | - |
| dc.identifier.citation | Reproductive and Developmental Medicine, 2022, v. 6, n. 4, p. 234-242 | - |
| dc.identifier.issn | 2096-2924 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/368142 | - |
| dc.description.abstract | This review summarizes the drugs and chemicals that may modulate embryo implantation. Non-hormonal molecules, including aspirin, improved endometrial blood flow, while low molecular weight heparin, vitamin E, sildenafil, and atosiban modulated the expression of endometrial genes. Hormonal factors, including human chorionic gonadotropin and growth hormones, can regulate the expression of endometrial receptivity markers. Other immunomodulatory molecules, including granulocyte colony-stimulating factor, peripheral blood mononuclear cells, autologous platelet-rich plasma, and intralipid and intravenous immunoglobulins, may improve implantation rate by modulating endometrial immune functions. Medicinal extracts of the Chinese herbs Paeonia lactiflora and Perilla frutescens increased the expression of leukemia inhibitory factors in endometrial epithelial cells. Recently, the use of the commercially available Library of Pharmacologically Active Compounds with a high-throughput screening method has provided an approach to screen for compounds that may potentially enhance or suppress embryo implantation. Whether these biomedical findings translate into clinical effects that enhance or suppress embryo implantation requires further investigation. | - |
| dc.language | eng | - |
| dc.publisher | Wolters Kluwer Health | - |
| dc.relation.ispartof | Reproductive and Developmental Medicine | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | Birth control | - |
| dc.subject | Embryo implantation | - |
| dc.subject | Emergency contraception | - |
| dc.subject | Endometrial receptivity | - |
| dc.subject | In vitro fertilization | - |
| dc.subject | Repeated implantation failure | - |
| dc.title | Use of biological and chemical molecules in regulating embryo implantation and endometrial receptivity | - |
| dc.type | Article | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.doi | 10.1097/RD9.0000000000000027 | - |
| dc.identifier.scopus | eid_2-s2.0-85143657870 | - |
| dc.identifier.volume | 6 | - |
| dc.identifier.issue | 4 | - |
| dc.identifier.spage | 234 | - |
| dc.identifier.epage | 242 | - |
| dc.identifier.eissn | 2589-8728 | - |
| dc.identifier.issnl | 2096-2924 | - |
